STOCK TITAN

Amgen To Present At The Cowen 4th Annual IO Summit

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Amgen will present at the Cowen 4th Annual Virtual IO Summit on November 13, 2020, at 3:30 p.m. ET. David M. Reese, M.D., executive vice president of Research and Development, will lead the presentation. Live audio will stream from Amgen's website, with a replay available for 90 days post-event. Amgen, a leader in biotechnology since 1980, focuses on innovative human therapeutics to address serious illnesses and unmet medical needs. The company is dedicated to improving health outcomes globally.

Positive
  • None.
Negative
  • None.

THOUSAND OAKS, Calif., Nov. 10, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Cowen 4th Annual Virtual IO Summit at 3:30 p.m. ET on Friday, November 13, 2020. David M. Reese, M.D., executive vice president of Research and Development at Amgen will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen's website for at least 90 days following the event.

About Amgen 
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.  

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.  

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.  

CONTACT: Amgen, Thousand Oaks 
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631(media) 
Arvind Sood, 805-447-1060 (investors) 

Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-cowen-4th-annual-io-summit-301170200.html

SOURCE Amgen

FAQ

What time will Amgen's presentation at the Cowen 4th Annual Virtual IO Summit take place?

Amgen's presentation will take place at 3:30 p.m. ET on November 13, 2020.

Who will represent Amgen at the Cowen 4th Annual Virtual IO Summit?

David M. Reese, M.D., executive vice president of Research and Development, will present at the summit.

Where can I access the live audio of Amgen's presentation at the Cowen summit?

The live audio can be accessed from the Events Calendar on Amgen's website.

Will there be a replay of Amgen's presentation available?

Yes, a replay of the webcast will be available for at least 90 days following the event.

What is Amgen's focus in biotechnology?

Amgen is focused on discovering and delivering innovative human therapeutics for serious illnesses and unmet medical needs.

Amgen Inc

NASDAQ:AMGN

AMGN Rankings

AMGN Latest News

AMGN Stock Data

150.64B
536.44M
0.25%
81.23%
1.74%
Drug Manufacturers - General
Biological Products, (no Disgnostic Substances)
Link
United States of America
THOUSAND OAKS